"Designing Growth Strategies is in our DNA"

Idiopathic Inflammatory Myopathy Treatment Market Size, Share & Industry Analysis, By Disease Type (Dermatomyositis, Polymyositis, Necrotizing Autoimmune Myopathy, Others), By Treatment (Corticosteroids, Immunosuppressants, Others), By Route of Administration (Oral, Intravenous, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026

The global idiopathic inflammatory myopathy treatment market size stood at USD 652.3 million in 2018 and is projected to reach USD 930.6 million by 2026, exhibiting a CAG... Read More

Final report will be updated to address the impact of COVID-19 on this particular market

Region : Global | Published Date: Jan, 2020 | Report ID: FBI100198 | Status : Published

 

Inquire Before Buying

Refresh Button
Idiopathic Inflammatory Myopathy Treatment Market Size, Share and Global Industry Trend Forecast till 2025
  • PDF
  • 2018
  • 2015-2017
  • 159
  • Direct Purchase
  • 4850
    6850
    8850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver


We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X